The Role of Recombinant Glycodelin in the Differentiation of Regulatory T-Lymphocytes

Dokl Biol Sci. 2022 Oct;506(1):137-140. doi: 10.1134/S0012496622050131. Epub 2022 Oct 27.

Abstract

The effect of recombinant glycodelin (GdA) on the number of T-regulatory lymphocytes (Treg) in a culture of activated CD4+ lymphocytes was investigated, while simultaneously assessing the proliferative status of the cells. Recombinant GdA from E. coli and from HEK293 cells were used in the study at concentrations of 0.2; 2 and 10 µg/mL. It was found that only a low concentration (0.2 μg/mL) of recombinant GdA of bacterial origin reduced the number of proliferating CD4+ lymphocytes as well as the number of Treg (CD4+CD25highCD127-/low) in the experimental system in vitro.

MeSH terms

  • Escherichia coli
  • Glycodelin
  • HEK293 Cells
  • Humans
  • Interleukin-7 Receptor alpha Subunit* / metabolism
  • T-Lymphocytes, Regulatory*

Substances

  • Glycodelin
  • Interleukin-7 Receptor alpha Subunit